Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney Function

← catalyst calendar

NCT06559527

Sponsored by Novo Nordisk A/S (industry) · NVO — their whole pipeline →.

Phase
Phase 1
Status
Completed
Study type
Interventional
Design
Non randomized · None · Treatment
Enrollment
42actual
Sites
1
Country
Germany

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2024-08-20actualWhen the study began enrolling
Primary completion2025-02-24actualThe date the last participant is measured for the primary outcome — the readout window
Study completion2025-03-05actualThe whole study's end, after follow-up
First posted2024-08-19actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2025-03-30actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

  • Diabetes Mellitus, Type 2
  • Obesity
  • Overweight

Intervention

  • Drug: NNC0487-0111

Primary outcome

what the primary-completion date above is the date OF
AUC0111,0-∞,SD: Area under the NNC0487-0111 plasma concentration-time curve from time 0 to infinity after a single dose
measured From baseline (Visit 2, Day 1, pre-dose) until completion of the end of study visit (Visit 9, Day 28)

Publications

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · NVO's whole pipeline · Catalyst calendar · Every registered study · What changed